Overnight levels of luteinizing hormone, follicle-stimulating hormone and growth hormone before and during gonadotropin-releasing hormone analogue treatment in short boys born small for gestational age

Hormone Research

Volumn 71, Issue 5, 2009, Pages 260-267

  Van Der Kaay, Daniëlle C M ^a,b   De Jong, Frank H ^a   Rose, Susan R ^f   Odink, Roelof J H ^c   Bakker Van Waarde, Willie M ^d   Sulkers, Eric J ^e   Hokken Koelega, Anita C S ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Dutch Growth Research Foundation   (Netherlands)

^c CATHARINA HOSPITAL   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e Ziekenhuis Walcheren   (Netherlands)

^f UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Follicle stimulating hormone levels; Gonadotropin releasing hormone analogue treatment; Growth hormone levels; Luteinizing hormone levels; Small for gestational age

Indexed keywords

FOLLITROPIN; LEUPRORELIN; LUTEINIZING HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BODY HEIGHT; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; EVALUATION; FOLLITROPIN BLOOD LEVEL; GESTATIONAL AGE; GONADORELIN TEST; GROWTH DISORDER; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBERTY; SHORT STATURE; SIDE EFFECT; SMALL FOR DATE INFANT; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION; TREATMENT RESPONSE;

BODY HEIGHT; CHILD; FOLLICLE STIMULATING HORMONE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LEUPROLIDE; LUTEINIZING HORMONE; MALE; PUBERTY, PRECOCIOUS;

EID: 63349090349     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000208799     Document Type: Article

References (43)

1. Albertsson-Wikland K, Karlberg J: Natural growth in children born small for gestational age with and without catch-up growth. Acta Paediatr Suppl 1994; 399:64-70, discussion 71.
2. Hokken-Koelega AC, De Ridder MA, Lem-men RJ, Den Hartog H, De Muinck Keizer-Schrama SM, Drop SL: Children born small for gestational age: do they catch up? Pediatr Res 1995; 38:267-271.
3. Boguszewski M, Rosberg S, Albertsson-Wikland K: Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children. J Clin Endocrinol Metab 1995; 80:2599-2606.
4. de Waal WJ, Hokken-Koelega AC, Stijnen T, de Muinck Keizer-Schrama SM, Drop SL: Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone. Clin Endocrinol (Oxf) 1994; 41:621-630.
5. Sas T, de Waal W, Mulder P, Houdijk M, Jan-sen M , Ree s e r M, Hok k e n-Koelega A:Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial. J Clin Endocrinol Metab 1999; 84: 3064-3070.
6. Verkauskiene R, Jaquet D, Deghmoun S, Chevenne D, Czernichow P, Levy-Marchal C: Smallness for gestational age is associated with persistent change in insul in-like growth factor I (IGF-I) and the ratio of IGF-I/IGF-binding protein-3 in adulthood. J Clin Endo-crinol Metab 2005; 90: 5672-5676.
7. Stanhope R, Ackland F, Hamill G, Clayton J, Jones J, Preece MA: Physiological growth hormone secretion and response to growth hormone treatment in children with short stature and intrauterine growth retardation. Acta Paediatr Scand Suppl 1989; 349: 47-52, discussion 53-54.
8. Hokken-Koelega AC: Timing of puberty and fetal growth. Best Pract Res Clin Endocrinol Metab 2002; 16:65-71.
9. Boonstra V, van Pareren Y, Mulder P, Hok-ken-Koelega A: Puberty in growth hormone-treated children born small for gestational age (SGA). J Clin Endocrinol Metab 2003; 88: 5753-5758.
10. Mul D, Bertelloni S, Carel JC, Saggese G, Chaussain JL, Oostdijk W: Effect of gonado-tropin-releasing hormone agonist treatment in boys with central precocious puberty: final height resu lts. Horm Res 2002; 58: 1-7.
11. Dunkel L, Alfthan H, Stenman UH, Selstam G, Rosberg S, Albertsson-Wikland K: De vel-opmental changes in 24-hour profiles of lu-teinizing hormone and follicle-stimulating hormone from prepuberty to midstages of puberty in boys. J Clin Endocrinol Metab 1992; 74: 890-897.
12. Albertsson-Wikland K, Rosberg S, Lanne ring B, Dunkel L, Selstam G, Norjavaara E: Twenty-four-hour profiles of luteinizing hormone, follicle-stimulating hormone, testosterone, and estradiol levels: a semilongitudinal study throughout puberty in healthy boys. J Clin Endocrinol Metab 1997; 82: 541-549.
13. Wennink JM, Delemarre-van de Waal HA, Schoemaker R, Schoemaker H, Schoemaker J: Luteinizing hormone and follicle stimulating hormone secretion patterns in boys throughout puberty measured using highly sensitive immunoradiometric assays. Clin Endocrinol (Oxf) 1989; 31:551-564.
14. Oerter KE, Uriarte MM, Rose SR, Barnes KM, Cutler GB Jr: Gonadotropin secretory dynamics during puberty in normal girls and boys. J Clin Endocrinol Metab 1990; 71: 1251-1258.
15. Roger M, Lahlou N, Lindner D, Chaussain JL: Gonadotropin-releasing hormone testing in pediatrics; in Ranke MD (ed): Functional Endocrinologic Diagnostics in Children and Adolescents. Mannheim, J&J Verlag, 1992, pp 229-247.
16. Tato L, Saggese G, Cavallo L, Antoniazzi F, Corrias A, Pasquino AM, Cisternino M: Use of combined Gn-RH agonist and hGH therapy for better attaining the goals in precocious puberty treatment. Horm Res 1995; 44(suppl 3):49-54.
17. Saggese G, Bertelloni S, Baroncelli GI, Di Nero G, Battini R: Growth velocity and serum aminoterminal propeptide of type III procollagen in precocious puberty during gonadotropin-releasing hormone analogue treatment. Acta Paediatr 1993; 82: 261-266.
18. Walvoord EC, Pescovitz OH: Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty: theoretic and practical considerations. Pediatrics 1999; 104:1010-1014.
19. Carel JC, Hay F, Coutant R, Rodrigue D, Chaussain JL: Gonadotropin-releasing hormone agonist treatment of girls with constitutional short stature and normal pubertal development. J Clin Endocrinol Metab 1996; 81:3318-3322.
20. Kamp GA, Manasco PK, Barnes KM, Jones J, Rose SR, Hill SC, Cutler GB Jr: Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty. J Clin Endocrinol Metab 1991; 72: 301-307.
21. DiMartino-Nardi J, Wu R, Fishman K, Saenger P: The effect of long-acting analog of luteinizing hormone-releasing hormone on growth hormone secretory dynamics in children with precocious puberty. J Clin Endo-crinol Metab 1991; 73: 902-906.
22. Stanhope R, Pringle PJ, Brook CG: Growth, growth hormone and sex steroid secretion in girls with central precocious puberty treated with a gonadotrophin releasing hormone (GnRH) analogue. Acta Paediatr Scand 1988; 77: 525-530.
23. Usher R, McLean F: Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr 1969; 74:901-910.
24. Fredriks AM, van Buuren S, Burgmeijer RJ, Meulmeester JF, Beuker RJ, Brugman E, Roede MJ, Verloove-Vanhorick SP, Wit JM: Continuing positive secular growth change in The Netherlands 1955-1997. Pediatr Res 2000; 47: 316 - 323.
25. Tanner JM, Whitehouse RH: Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976; 51: 170-179.
26. Cavallo A, Zhou XH: LHRH test in the assessment of puberty in normal children. Horm Res 1994; 41:10-15.
27. Pyle SI, Waterhouse AM, Greulich WW: Attributes of the radiographic standard of reference for the National Health Examination Sur vey. Am J Phys Anthropol 1971; 35: 331-337.
28. Boot AM, Bouquet J, de Ridder MA, Kren-ning EP, de Muinck Keizer-Schrama SM: Determinants of body composition measured by dual-energy x-ray absorptiometry in Dutch children and adolescents. Am J Clin Nutr 1997; 66:232-238.
29. Mul D, de Muinck Keizer-Schrama SM, Oostdijk W, Drop SL: Auxological and biochemical evaluation of pubertal suppression with the GnRH agonist leuprolide acetate in early and precocious puberty. Horm Res 1999; 51: 270-276.
30. Ibanez L, Potau N, Zampolli M, Virdis R, Gussinye M, Carrascosa A, Saenger P, Vicens-Calvet E: Use of leuprolide acetate response patterns in the early diagnosis of pubertal disorders: comparison with the gonadotropin- releasing hormone test. J Clin Endocrinol Metab 1994; 78: 30-35.
31. Rose SR, Municchi G, Barnes KM, Kamp GA, Uriarte MM, Ross JL, Cassorla F, Cutler GB Jr: Spontaneous growth hormone secretion increases during puberty in normal girls and boys. J Clin Endocrinol Metab 1991; 73: 428-435.
32. Morsky P, Tiikkainen U, Ruokonen A, Mark-kanen H: Problematic determination of serum growth hormone: experience from external quality assurance surveys 1998-2003. Scand J Clin Lab Invest 2005; 65:377-386.
33. Hokken-Koelega AC, Hackeng WH, Stijnen T, Wit JM, de Muinck Keizer-Schrama SM, Drop SL: Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation. J Clin Endocrinol Metab 1990; 71: 688-695.
34. Rikken B, van Doorn J, Ringeling A, Van den Brande JL, Massa G, Wit JM: Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency. Horm Res 1998; 50: 166-176.
35. Merriam GR, Wachter KW: Algorithms for the study of episodic hormone secretion. Am J Physiol 1982; 243:E310-E318.
36. Cook JS, Doty KL, Conn PM, Hansen JR: Assessment of depot leuprolide acetate dose-adequacy for central precocious puberty. J Clin Endocrinol Metab 1992; 74:1206-1209.
37. Volkl TM, Schwobel K, Simm D, Beier C, Rohrer TR, Dorr HG: Spontaneous growth hormone secretion and IGF1:IGFBP3 molar ratios in children born small for gestational age (SGA). Grow th Horm IGF Res 2004; 14:455-461.
38. Boonstra VH, Arends NJ, Stijnen T, Blum WF, Akkerman O, Hokken-Koelega AC: Food intake of children with short stature born small for gestational age before and during a randomized GH trial. Horm Res 2006; 65: 23-30.
39. Carrascosa A, Esteban C, Espadero R, Fer-nandez-Cancio M, Andaluz P, Clemente M, Audi L, Wollmann H, Fryklund L, Parodi L: The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patients. J Clin En-docrinol Metab 2006; 91: 3281-3286.
40. Carel JC, Chatelain P, Rochiccioli P, Chaus-sain JL: Improvement in adult height after growth hormone treatment in adolescents with short stature born small for gestational age: results of a randomized controlled study. J Clin Endocrinol Metab 2003; 88: 1587-1593.
41. Johnston LB, Dahlgren J, Leger J, Gelander L, Savage MO, Czernichow P, Wikland KA, Clark AJ: Association between insulin-like growth factor I (IGF-I) polymorphisms, circulating IGF-I, and pre- and postnatal growth in two European small for gestation-al age populations. J Clin Endocrinol Metab 2003; 88: 4805-4810.
42. Blum WF, Albertsson-Wikland K, Rosberg S, Ranke MB: Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secret ion. J Clin Endocrinol Metab 1993; 76:1610-1616.
43. Albertsson-Wikland K, Rosberg S: Reproducibility of 24-h growth hormone profiles in children. Acta Endocrinol (Copenh) 1992; 126:109-112.